Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Smartphone app could screen for Alzheimer’s disease

May 4, 2022 Research and Development

Researchers at the University of California San Diego have developed a smartphone app with the potential to screen for Alzheimer’s …
News

WHO announce upcoming updates on treatment of drug-resistant tuberculosis

May 4, 2022 Research and Development

A rapid communication released by WHO Global Tuberculosis Programme has announced upcoming updates to the guidance on the treatment of …
News

Quell Therapeutics and Cellistic collaborate to develop T-regulatory cell therapy platform

April 27, 2022 Research and Development

Quell Therapeutics and Cellistic have entered into a strategic collaboration for the co-development of an iPSC-derived Treg cell therapy platform. …
News

Gesynta Pharma receives orphan drug designation by FDA for systemic sclerosis

April 27, 2022 Research and Development

Orexo has announced that their partner, Gesynta Pharma has been granted Orphan Drug Designation by the FDA, for OX-MPI (GS248), …
News

Enhertu granted FDA Breakthrough Therapy Designation

April 27, 2022 Research and Development

AstraZeneca’s Enhertu® (fam-trastuzumab deruxtecan-nxki) has been granted breakthrough therapy designation in the US for adult patients with HER2-low metastatic breast …
News

Takeda Nuvaxovid COVID-19 vaccine approved in Japan

April 20, 2022 Research and Development

Takeda’s Nuvaxovid Intramuscular Injection (Nuvaxovid) has been approved by the Japan Mnistry of Health, Labour and Welfare (MHLW). This is …
News

Care to Collaborate: Cydar Medical announces partnership with Medtronic

April 20, 2022 Research and Development

Cydar Medical has announced a strategic collaboration with leading healthcare technology company Medtronic. Under the pilot arrangement, Cydar’s EV Maps …
News

Study initiated for first miniaturised robotic-assisted surgery platform

April 20, 2022 Research and Development

Virtual Incision Corporation has announced the FDA approval of an Investigational Device Exemption (IDE) supplement to complete the final stage …
News

NHS Health Chief calls for return of facemasks and social distancing

April 20, 2022 Research and Development

Chris Hopson, Chief Executive of NHS Providers, which represents trusts has urged ministers to discuss “sensible precautions” for the public, …
News

VistaGen and AffaMed complete regulatory submissions for Phase III SAD trial

April 13, 2022 Research and Development

VistaGen and AffaMed have announced the completion of key regulatory preparations to initiate PALISADE global, a Phase III clinical trial …
News

NICE recommends avelumab for urothelial cancer patients

April 13, 2022 Research and Development

NICE has recommended avelumab as treatment for adults with locally advanced or metastatic urothelial cancer.The treatment, avelumab, will benefit over …
News

FDA and DEA warn online pharmacies illegally selling ADHD drug Adderall

April 13, 2022 Research and Development

The FDA and the US DEA have jointly issued warning letters to operators of two websites illegally selling Schedule II …
News

It could take up to six years to clear the patient backlog in Europe

April 13, 2022 Research and Development

Research has found that oncologists and surgeons across Europe estimate it will take at least three years to clear the …
News

Nine more COVID-19 symptoms added to list

April 6, 2022 Research and Development

Nine new symptoms, including sore throat, fatigue, and headache, have been added to the official list of COVID-19 symptoms on …
News

UK Government accused of failing to address cancer staff shortages

April 6, 2022 Research and Development

MPs have warned that urgent steps are needed to prevent the UK from losing gains made in recent years on …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026